🧬 AMPLIFY-7P: Primary DFS endpoint not met.

OncoDaily IO· @OncoDailyIO · X·2026-10-23 21:55· 2 days agoScore70

Body

https://oncodaily.com/oncolibrary/immune-oncology/amplify-7p

In 144 patients with resected KRAS-mutated PDAC, camupepimut (ELI-002 7P) vs observation:
⏳ Median DFS: 23.8 vs 21.2 months
📊 HR 0.85; P=0.5329
No significant DFS improvement.
#ESMO2026 #OncoDaily #ESMO26

109 views · 1 like · 0 reposts · 0 replies

Conference abstracts

7Pmatched by Proffered paper 1: Gastrointestinal tumour, upper digestive

Proffered paper 1: Gastrointestinal tumour, upper digestive

https://esmocongress.esmo.org

Source: OncoDaily IO · x.com